1. Home
  2. AGX vs LGND Comparison

AGX vs LGND Comparison

Compare AGX & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGX
  • LGND
  • Stock Information
  • Founded
  • AGX 1961
  • LGND 1987
  • Country
  • AGX United States
  • LGND United States
  • Employees
  • AGX N/A
  • LGND N/A
  • Industry
  • AGX Engineering & Construction
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • AGX Consumer Discretionary
  • LGND Health Care
  • Exchange
  • AGX Nasdaq
  • LGND Nasdaq
  • Market Cap
  • AGX 2.1B
  • LGND 2.3B
  • IPO Year
  • AGX N/A
  • LGND 1992
  • Fundamental
  • Price
  • AGX $139.58
  • LGND $114.64
  • Analyst Decision
  • AGX Buy
  • LGND Strong Buy
  • Analyst Count
  • AGX 3
  • LGND 6
  • Target Price
  • AGX $123.33
  • LGND $145.00
  • AVG Volume (30 Days)
  • AGX 317.4K
  • LGND 134.9K
  • Earning Date
  • AGX 12-05-2024
  • LGND 11-07-2024
  • Dividend Yield
  • AGX 1.08%
  • LGND N/A
  • EPS Growth
  • AGX 92.83
  • LGND 160.46
  • EPS
  • AGX 4.81
  • LGND 2.47
  • Revenue
  • AGX $806,259,000.00
  • LGND $152,422,000.00
  • Revenue This Year
  • AGX $35.03
  • LGND $26.86
  • Revenue Next Year
  • AGX $11.83
  • LGND $13.16
  • P/E Ratio
  • AGX $28.99
  • LGND $46.38
  • Revenue Growth
  • AGX 52.83
  • LGND N/A
  • 52 Week Low
  • AGX $43.44
  • LGND $67.53
  • 52 Week High
  • AGX $165.33
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • AGX 43.84
  • LGND 46.50
  • Support Level
  • AGX $137.47
  • LGND $113.39
  • Resistance Level
  • AGX $150.83
  • LGND $124.03
  • Average True Range (ATR)
  • AGX 8.89
  • LGND 5.75
  • MACD
  • AGX -1.92
  • LGND -1.02
  • Stochastic Oscillator
  • AGX 21.86
  • LGND 21.59

About AGX Argan Inc.

Argan Inc is a United States-base construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derive majority revenue.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: